NO965556L - Trippelkombinasjon mot HIV - Google Patents

Trippelkombinasjon mot HIV

Info

Publication number
NO965556L
NO965556L NO965556A NO965556A NO965556L NO 965556 L NO965556 L NO 965556L NO 965556 A NO965556 A NO 965556A NO 965556 A NO965556 A NO 965556A NO 965556 L NO965556 L NO 965556L
Authority
NO
Norway
Prior art keywords
against hiv
triple combination
combination against
aids
lamivudine
Prior art date
Application number
NO965556A
Other languages
English (en)
Other versions
NO965556D0 (no
Inventor
Paulus Aloysius Maria Stoffels
Koenraad Jozef Lodewijk
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO965556D0 publication Critical patent/NO965556D0/no
Publication of NO965556L publication Critical patent/NO965556L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse vedrører en terapeutisk kombinasjon omfattende zidovudin, lamivudin og lovi- rid for behandling av "Human Immonodeficiency Virus» (AIDS) eller AIDS-relatert kompleks (ARC).
NO965556A 1994-07-01 1996-12-23 Trippelkombinasjon mot HIV NO965556L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94201897 1994-07-01
PCT/EP1995/002462 WO1996001110A2 (en) 1994-07-01 1995-06-23 Anti-hiv triple combination

Publications (2)

Publication Number Publication Date
NO965556D0 NO965556D0 (no) 1996-12-23
NO965556L true NO965556L (no) 1996-12-23

Family

ID=8217000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965556A NO965556L (no) 1994-07-01 1996-12-23 Trippelkombinasjon mot HIV

Country Status (25)

Country Link
EP (1) EP0768881B1 (no)
JP (1) JP2945481B2 (no)
KR (1) KR100218495B1 (no)
CN (1) CN1091599C (no)
AP (1) AP9600896A0 (no)
AT (1) ATE218867T1 (no)
AU (1) AU693911B2 (no)
BG (1) BG101175A (no)
BR (1) BR9508201A (no)
CA (1) CA2193489A1 (no)
CZ (1) CZ375596A3 (no)
DE (1) DE69527066T2 (no)
EE (1) EE9600180A (no)
FI (1) FI965292A0 (no)
HU (1) HUT77720A (no)
IL (1) IL114415A0 (no)
MX (1) MX9700044A (no)
MY (1) MY130597A (no)
NO (1) NO965556L (no)
OA (1) OA10341A (no)
PL (1) PL317891A1 (no)
SK (1) SK168196A3 (no)
TW (1) TW401303B (no)
WO (1) WO1996001110A2 (no)
ZA (1) ZA955471B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008539A1 (en) * 1996-08-26 1998-03-05 Chiron Corporation Postinfection human immunodeficiency virus (hiv) vaccination therapy
EP0872233A1 (en) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
PT1225874E (pt) 1999-09-24 2006-06-30 Janssen Pharmaceutica Nv Composicoes antivirais.
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
US9044509B2 (en) 2006-02-03 2015-06-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inhibition of HIV infection through chemoprophylaxis
CL2008000746A1 (es) 2007-03-14 2008-09-22 Tibotec Pharm Ltd Composicion farmaceutica en solucion que comprende tmc278 y un polimero soluble en agua; proceso de preparacion de dicha composicion; y uso de un polvo que comprende tmc278 para tratar sida.
WO2010137027A1 (en) 2009-05-27 2010-12-02 Hetero Research Foundation Solid oral dosage forms of lamivudine
US20210128554A1 (en) * 2016-12-23 2021-05-06 Temple University - Of The Commonwealth System Of Higher Education Anti-flaviviridae activity of anti-retroviral non-nucleoside (nnrtis) and nucleoside reverse transcriptase inhibitors (nnrtis)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs

Also Published As

Publication number Publication date
ZA955471B (en) 1996-12-30
AU2924895A (en) 1996-01-25
HUT77720A (hu) 1998-07-28
WO1996001110A3 (en) 1996-02-22
BR9508201A (pt) 1997-11-11
DE69527066T2 (de) 2003-02-13
CA2193489A1 (en) 1996-01-18
FI965292A (fi) 1996-12-31
FI965292A0 (fi) 1996-12-31
AP9600896A0 (en) 1997-01-31
SK168196A3 (en) 1997-05-07
CN1151697A (zh) 1997-06-11
EE9600180A (et) 1997-06-16
EP0768881B1 (en) 2002-06-12
WO1996001110A2 (en) 1996-01-18
JP2945481B2 (ja) 1999-09-06
BG101175A (en) 1997-08-29
CN1091599C (zh) 2002-10-02
NO965556D0 (no) 1996-12-23
ATE218867T1 (de) 2002-06-15
JPH09507858A (ja) 1997-08-12
AU693911B2 (en) 1998-07-09
TW401303B (en) 2000-08-11
MY130597A (en) 2007-07-31
EP0768881A2 (en) 1997-04-23
KR100218495B1 (en) 1999-09-01
HU9603627D0 (en) 1997-02-28
IL114415A0 (en) 1995-10-31
DE69527066D1 (de) 2002-07-18
OA10341A (en) 1997-10-07
PL317891A1 (en) 1997-04-28
CZ375596A3 (en) 1997-04-16
MX9700044A (es) 1997-04-30

Similar Documents

Publication Publication Date Title
EP0831873A4 (en) COMBINATORY THERAPY FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS
AU2452288A (en) Nucleoside derivatives useful in treating retroviral infections
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
ZA913910B (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
DK92788D0 (da) Ny medicinsk anvendelse
ITFI920078A0 (it) Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umana.
AU8090087A (en) The use of 3-deoxy-thymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
NO965556L (no) Trippelkombinasjon mot HIV
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU5848794A (en) Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
EP0621788A4 (en) Hemoregulatory peptides.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
NO981564D0 (no) Terapeutisk administrering av hemoglobin ved hjertestans
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
HK1010985A1 (en) The use of 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) for the preparation of a medicament for the treatment of arboviruses
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
PL317876A1 (en) Combined treatment of hiv infections
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
WO1998044913A3 (en) Compositions containing mkc-442 in combination with other antiviral agents
AP9801368A0 (en) Benzamide treatment of mentia associated with HIV AIDS VIRUS (HIV-1) infection
AU1189899A (en) Inhibition of human immunodeficiency virus (hiv-1) replication
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
AP9901681A0 (en) Antiviral composition containing oxidized inositol, sodium sulfite, pyrocatechol and copper sulfate.
MX9706942A (es) Compuestos quimicos.